Welcome to LookChem.com Sign In|Join Free

CAS

  • or

383382-84-1

Post Buying Request

383382-84-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

383382-84-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 383382-84-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,8,3,3,8 and 2 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 383382-84:
(8*3)+(7*8)+(6*3)+(5*3)+(4*8)+(3*2)+(2*8)+(1*4)=171
171 % 10 = 1
So 383382-84-1 is a valid CAS Registry Number.

383382-84-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 3,4-dihydroxy-2-nitrobenzophenone

1.2 Other means of identification

Product number -
Other names BIA 8-176

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:383382-84-1 SDS

383382-84-1Downstream Products

383382-84-1Relevant articles and documents

Synthesis and biological evaluation of a novel series of "ortho-nitrated" inhibitors of catechol-O-methyltransferase

Learmonth, David A.,Bonifácio, Maria Jo?o,Soares-Da-Silva, Patricio

, p. 8070 - 8078 (2007/10/03)

Novel regioisomeric "ortho-nitrated" catechols related to the catechol-O-methyltransferase (COMT) inhibitors BIA 3-202 3 and BIA 3-335 4 were synthesized and biologically evaluated. Changing the position of the nitro group from the "classical" meta- to th

Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them

-

Example 61, (2008/06/13)

New compounds of formula I are described: The compounds have potentially valuable pharmaceutical properties in the treatment of some central and peripheral nervous system disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 383382-84-1